Mild cognitive impairment is widely viewed as an early stage of dementia but, as a new study highlights, some people never progress, and might even revert to normal cognition. Poor predictive validity of prodromal conditions has clear implications for the principle of 'do no harm', as overtreatment becomes a possibility.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Prolonged or serious conflicts at work and incident dementia: a 23-year follow-up of the Copenhagen City Heart Study
International Archives of Occupational and Environmental Health Open Access 28 October 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183–194 (2004).
Vellas, B. et al. Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement. 9, 438–444 (2013).
Roberts, R. O. et al. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology 82, 317–325 (2014).
Gao, S. et al. Mild cognitive impairment, incidence, progression, and reversion: findings from a community-based cohort of elderly African Americans. Am. J. Geriatr. Psychiatry http://dx.doi.org/10.1016/j.jagp.2013.02.015.
Sachdev, P. S. et al. Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study. PLoS ONE 8, e59649 (2013).
Ward, A., Tardiff, S., Dye, C. & Arrighi, H. M. Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature. Dement. Geriatr. Cogn. Dis. Extra 3, 320–332 (2013).
Fox, C. et al. Screening for dementia—is it a no brainer? Int. J. Clin. Pract. 67, 1076–1080 (2013).
Stephan, B. et al. Optimizing mild cognitive impairment for discriminating dementia risk in the general older population. Am. J. Geriatr. Psychiatry 18, 662–673 (2010).
Dubois, B. et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 9, 1118–1127 (2010).
Richard, E. et al. MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study. BMJ Open 3, e002541 (2013).
Acknowledgements
The authors thank Blossom Stephan for substantial and constructive comments.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Richard, E., Brayne, C. Mild cognitive impairment—not always what it seems. Nat Rev Neurol 10, 130–131 (2014). https://doi.org/10.1038/nrneurol.2014.23
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2014.23
This article is cited by
-
Prolonged or serious conflicts at work and incident dementia: a 23-year follow-up of the Copenhagen City Heart Study
International Archives of Occupational and Environmental Health (2019)